Conference Dates: 3-4th October, 2011
Venue: London, UK

Phase IV clinical trials and observational studies are two of the fastest growing areas of clinical research. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which proves efficacy, safety and quality. Furthermore, a key driver for these types of studies are the demands of health technology assessors and payers and their need for evidence-based economic data, again over the long-term.

As phase IV and observational studies tend to be more commercial in nature, successfully planning and implementing them can be a major challenge, especially in terms of motivating investigators and recruiting patients who may already have access to the latest medications. Observational data whilst demonstrating actual patient and prescriber behavior also presents the additional challenge of the issue of bias and regulatory acceptance.

This event will provide the latest and most value-adding, real-life experiences in post-marketing studies, their benefits and challenges. It will be an ideal opportunity for benchmarking and networking with the experts and will bring the post-marketing community together to discuss solutions to the challenges in this vital area of research.

Why Attend?

- Gain access to the latest methodologies and real-life cases in the field.
- Explore how market leaders are improving data capture and accuracy.
- Learn how to Balance the complex requirements of key stakeholders: marketing, clinical, regulatory, safety, KOLs and investigators.
- Learn more about comparative studies and their value for drug evaluation.
- Understand how late-phase studies are utilized to support corporate goals.
- Get updated with the latest regulatory / ethical priorities and initiatives.
- Find out how phase IV studies & observational research are being outsourced and how industry players are selecting the right partners.

Agenda request

To request the full agenda please follow the link: see here.

Source:
NextLevel Pharma